ADA/NAb Testing & Reporting
Stand-alone NAb assay
New Approach Methodologies (NAM)
In silico/in vitro vs AI/ML prediction
Regulatory Feedback on S/N and 1-Tier
Pre-existing Ab meaningful interpretation
Immunogenicity for:
Peptides, oligonucleotide
ADC, Bi/Multispecifics, TCE
Gene therapies,
Next-generation biotherapeutics
Novel/complex modalities